FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

URL has been copied successfully!

The FDA approval of Eli Lilly’s GLP-1 pill Foundayo comes nearly three months after Novo Nordisk’s oral version of Wegovy hit the market.

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here